[Study of acefillinate of heptaminol-cinnarizine in cochleo-vestibular syndromes].
D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000008:administration & dosage*; D000818:Animals; D001299:Audiometry; D003638:Deafness / Q000188:drug therapy*; D004285:Dogs; D004585:Electrooculography; D006311:Hearing Disorders / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy; D008875:Middle Aged; D009759:Nystagmus, Pathologic / Q000503:physiopathology; D010879:Piperazines / Q000008:administration & dosage*; D012598:Sclerosis / Q000188:drug therapy; D014432:Tympanic Membrane; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology; D014717:Vertigo / Q000188:drug therapy*
D000605:Amino Alcohols; D006634:Histamine H1 Antagonists; D010879:Piperazines; D014665:Vasodilator Agents
Etude de l'Acéfillinate d'Heptaminol-Cinnarizine dans les syndromes cochléo-vestibulaires.